BEFOVACIMAB

UNII: 8FFQ0L4R3B
Preferred Substance Name: BEFOVACIMAB

2156634-62-5
BAY1093884
BAY-1093884
BEFOVACIMAB [INN]
HUMAN TISSUE FACTOR PATHWAY INHIBITOR-NEUTRALIZING ANTIBODY (BAY 1093884)
IMMUNOGLOBULIN G2, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL 1093884 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 1093884 .LAMBDA.-CHAIN, DIMER

Common Chemistry
i
Inxight Drugs
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

BEFOVACIMAB

Synonyms and Mappings

Resources

Note